Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Wins! Wells done. I didn't have the courage.
Still a long way to get to true value.....
And rising by 800/900k a quarter currently, with latest contract wins this should be circa 1 mill per quarter. I can see 40/50 mcap here in 6 months
I saw the sell off in the lead-up to this and was getting slightly twitchy. Great RNS - I think your explanation on EBITDA is bang on. Still a very good price I think at 20p - 3m in the bank. 14m MCAP an IPO in the wings - this has a lot more potential to back up this year to 28-30p easily.
I was lucky to get in at 16 and picked up another 100k first thing
they are also hiding some of the trades on Nex exchange (old ISDX), there are over 100k of shares bought there this morning that don't show on here, one of them is mine at 18.5
hold, first time I'll take a look is around 24, but even then just a topslice I imagine, from what I read below we've been given the opportunity by a possible seller who finished around 15
with revenues bang on expectations for last year. And the business is evidently continuing to thrive given the 5.7m euros of orders already booked this year. The share price fell to a ridiculous level imo based on small investors' stop losses being hit/the trading update taking longer than prior periods. Hopefully back to 25p-30p now. An update on EBITDA as per last year would have been preferable, but I suspect that discussions with auditors as to what to separate out above and below the line for Innovenn etc will go to the wire for the year end dependent on what happens and when with Integumen. It shouldn't be long before we get an update on the Integumen IPO, at which point no doubt the year end figures will be finalised. So hopefully further positive news flow soon!
Wonder how long it will take for the 'herd' to shift their obsession away from ANGS etc & not miss out on this the most genuinely substantial RNS gem of today.
like it .
I agree, I shouldn't have waited but I'm in today
Agreed Agamemnom. I was fearing there was someting untoward going on behind the scenes following the large fall in share price but this is a very good RNS.
Seriously impressive year end update...quote...'2016 represented another year of strong growth for Venn with sales in excess of €18m (2015 €11m). The business finished 2016 with a strong cash position of €3m (€1.75m 30 June 2016). The strong momentum enjoyed by the business in 2016 has continued into 2017 to-date, with new business contracts signed to the value €5.7m in the first two months of the year.'...unquote. New business this year alone equates to 1/2 the current market cap. Surely a serious rerate is justified.
thanks, thinking of investing here but tried to do a bit of searching on Pastern skneube within the rns's & a google search but came up with nothing, news to me and not within the shareholder information on the company site, anything you can add ? thanks £50k of director buys around 21 too I see
I could not disagree in most cases and a sensible and cautious approach. IMO looking at the trading Pastern skneube has been offloading their holding at a time when there was little demand. If the seller is done I expect the price to rise and the reverse if not. If a placing was on the cards more often then not there is a false rise beforehand. Anyway time will tell over the next week or so. ATB
imo there is always a reason for the drop, normally don't find out until the damage is done. Been keeping an eye here, and looked at the cash position and figured it may be dropping due to a coming placing, maybe for an acquisition for example ?
a position here day. Looks like all is on track for the integumen listing - looks like some initial crowd funding alongside IPO all going well so far - see CROWDFORANGELS.com
Meant 'could retrace quite quickly' IMO :)
Found nothing in public domain to account for current sp. My best guess is it's related to sentiment, hence good retrace quite quickly.
or I would hv a go. Hope this works out for LTH's. Would be good to get an idea from regular posters here what is afoot.
I note low point on graph. Can't seem to find Nominal value on IG but am on phone in the rain. Lowest point in 2015 is about 16p. Nominal value on Lse desktop site is 0.1p so it can go anywhere from here. Is it dipping down to touch a line on a graph? It's very early to fall so much and will now hv trouble getting back above the descending line. Also in no hurry at all today so I presume it is not finished. Clair1, any thoughts?
Great to see the sale of Innovenn proceeding smoothly and now completed per today's RNS: http://www.investegate.co.uk/venn-life-sciences--venn-/rns/completion-of-sale/201611180700075204P/ The IPO process takes some time - perhaps 2-3 months for a small cap like Integumen - so hopefully it may happen before Xmas, otherwise I can see it floating in early January. I expect the share price to move up nicely from here. With 2.39p EPS forecast this year, and 2.68p EPS next year, we now have a core business on almost a single-figure P/E, with cash in the bank, and a sizeable stake in a company about to IPO for a few more £m's.
Great news!
Great news - and since it starts immediately it will contribute to this year's results too, so the 2016 numbers should be extremely impressive given what we know. From now on, the markets will clearly see VENN's high and increasing profitability, which prior to the Innovenn sale was obscured by the expenses incurred in setting up and investing in Innovenn. This is reflected in the new analyst forecasts of 2.35p EPS this year 2.63p EPS next year. It's easy to extrapolate a 30p-35p share price based on this alone. On top of this, VENN will now have a 70% stake in Innovenn/Integumen. This could be worth a few £m in itself, especially post-IPO. VENN's current m/cap is still only £15m.
Substantial contract and starts straight away.